Comparison between Modern Diagnostic IPO and Snehaa Organics IPO.
Modern Diagnostic IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Snehaa Organics IPO is a SME Bookbuilding proposed to list at NSE SME.
| Modern Diagnostic IPO | Snehaa Organics IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Novus Capital Advisors Private Limited |
| Registrar | MUFG Intime India Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | Nirman Share Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Modern Diagnostic IPO is up to ₹35.04 Cr whereas the issue size of the Snehaa Organics IPO is up to ₹31.05 Cr. The final issue price of Modern Diagnostic IPO is ₹90.00 per share and of Snehaa Organics IPO is ₹122.00 per share.
| Modern Diagnostic IPO | Snehaa Organics IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹85.00 per share | ₹115.00 per share |
| Issue Price (Upper) | ₹90.00 per share | ₹122.00 per share |
| Issue Price (Final) | ₹90.00 per share | ₹122.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1000 shares |
| Fresh Issue Size | 38,92,800 shares | 25,45,000 shares |
| Fresh Issue Size (Amount) | up to ₹35.04 Cr | up to ₹31.05 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 38,92,800 shares | 25,45,000 shares |
| Issue Size Total (Amount) | up to ₹35.04 Cr | up to ₹31.05 Cr |
Modern Diagnostic IPO opens on Dec 31, 2025, while Snehaa Organics IPO opens on Aug 29, 2025. The closing date of Modern Diagnostic IPO and Snehaa Organics IPO is Jan 02, 2026, and Sep 02, 2025, respectively.
| Modern Diagnostic IPO | Snehaa Organics IPO | |
|---|---|---|
| Anchor Bid Date | Dec 30, 2025 | Aug 28, 2025 |
| Issue Open | Dec 31, 2025 | Aug 29, 2025 |
| Issue Close | Jan 02, 2026 | Sep 02, 2025 |
| Basis Of Allotment (Tentative) | Jan 05, 2026 | Sep 03, 2025 |
| Initiation of Refunds (Tentative) | Jan 06, 2026 | Sep 04, 2025 |
| Credit of Share (Tentative) | Jan 06, 2026 | Sep 04, 2025 |
| Listing date (Tentative) | Jan 07, 2026 | Sep 05, 2025 |
| Anchor Lockin End date 1 | Feb 03, 2026 | Oct 03, 2025 |
| Anchor Lockin End date 2 | Apr 04, 2026 | Dec 02, 2025 |
Modern Diagnostic IPO P/E ratio is 11.04, as compared to Snehaa Organics IPO P/E ratio of 12.47.
| Modern Diagnostic IPO | Snehaa Organics IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Modern Diagnostic & Research Centre Ltd.'s revenue increased by 15% and profit after tax (PAT) rose by 55% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Snehaa Organics Ltd.'s revenue increased by 10% and profit after tax (PAT) rose by 101% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 99.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.85 | 73.68 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.04 | 12.47 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹135.89 Cr. | ₹124.18 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 55.21 | 49.66 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.18 | 50.38 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.07 | 0.61 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.15 | ₹9.78 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 43.27 | 49.66 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Modern Diagnostic IPO Retail Individual Investors (RII) are offered 13,63,200 shares while in Snehaa Organics IPO retail investors are offered 13,63,200 shares. Qualified Institutional Buyers (QIB) are offered 7,82,400 shares in Modern Diagnostic IPO and 1,26,000 shares in Snehaa Organics IPO.
| Modern Diagnostic IPO | Snehaa Organics IPO | |
|---|---|---|
| Anchor Investor Reservation | 11,61,600 shares | 0 shares |
| Market Maker Reservation | 2,06,400 shares | 1,34,000 shares |
| QIB | 7,82,400 shares | 1,26,000 shares |
| NII | 5,85,600 shares | 12,09,000 shares |
| RII | 13,63,200 shares | 12,10,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 38,92,800 shares | 25,45,000 shares |
Modern Diagnostic IPO subscribed 376.90x in total, whereas Snehaa Organics IPO subscribed 27.75x.
| Modern Diagnostic IPO | Snehaa Organics IPO | |
|---|---|---|
| QIB (times) | 193.51x | 42.19x |
| NII (times) | 702.08x | 16.23x |
| Big NII (times) | 855.83x | 16.80x |
| Small NII (times) | 386.91x | 15.10x |
| RII (times) | 342.46x | 37.75x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 376.90x | 27.75x |
